ONMD stock forecast, quote, news & analysis

ONMD in +16.71% Uptrend, advancing for three consecutive days on September 08, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ONMD advanced for three days, in 109 of 145 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 04, 2026. You may want to consider a long position or call options on ONMD as a result. In 44 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.

The Moving Average Convergence Divergence (MACD) for ONMD just turned positive on September 04, 2026. Looking at past instances where ONMD's MACD turned positive, the stock continued to rise in 27 of 60 cases over the following month. The odds of a continued upward trend are 45%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ONMD moved below its 50-day moving average on September 11, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ONMD crossed bearishly below the 50-day moving average on August 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

ONMD broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ONMD entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. ONMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.171). P/E Ratio (38.927) is within average values for comparable stocks, (44.460). ONMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.499). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. ONMD's P/S Ratio (24.752) is very high in comparison to the industry average of (5.983).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.